MYLK
Top View
- Chemical Proteomics Reveals Target Selectivity of Clinical Jak Inhibitors in Human Primary Cells Received: 18 April 2019 H
- Myosin Light Chain Kinase Signaling in Endothelial Barrier Dysfunction
- Gene Expression in Sheep Carotid Arteries: Major Changes with Maturational Development
- A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
- Genetic Testing
- Targets and Off-Targets of Kinase Inhibitors in Diabetes
- Figures Paper 6-6-2021.Cdr
- AXL Confers Cell Migration and Invasion by Hijacking a PEAK1-Regulated Focal Adhesion Protein Network
- Aberrantly Methylated Genes in Human Papillary Thyroid Cancer and Their Association with BRAF/RAS Mutation
- Transposon Insertional Mutagenesis in Mice Identifies Human Breast Cancer Susceptibility Genes and Signatures for Stratification
- Non-Coding Rnas Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
- Genetic Testing Page 1 of 35
- Supplement Table S2
- Supplementary Material
- MLCK Kinase Assay by Juliano Alves, Ph.D., Said A
- Targeted-Sequencing Gene Panels Used by Each Hospital Huashan
- Supplementary Data
- S41467-020-15428-0.Pdf